Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors

July 10, 2025 updated by: I-Ching Hou, National Yang Ming Chiao Tung University

Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors: A Randomized Controlled Trial

The study addresses the pressing issue of overweight and obesity among breast cancer patients, which exacerbates recurrence rates and mortality risks. Its primary objective is to assess the efficacy of two intervention models, the Diet, Exercise, and Mindfulness (DEM) model and the Diet and Exercise (DE) model, in facilitating weight loss, enhancing self-efficacy, mindfulness, and quality of life. The anticipated outcomes include long-term engagement in online self-learning, overcoming the limitations of ineffective self-management learning, and empowering healthcare professionals with scenario-based teaching materials. Through online platforms, patients can learn and review without constraints, ultimately achieving a holistic balance among physical, mental, and spiritual health.

Study Overview

Detailed Description

[Research Background] Breast cancer ranks first among cancers in women worldwide, with overweight and obesity being one of the high-risk factors for breast cancer. Moreover, overweight individuals within the breast cancer patient population also face higher recurrence rates and mortality risks. Assisting overweight or obese breast cancer women in weight loss to promote their well-being was the initial idea behind this study. The most common weight loss strategies include dietary management and regular exercise. In recent years, more studies have shown that effective weight loss also requires psychological interventions. Therefore, this study will combine dietary, exercise, and mindfulness-related interventions to assist breast cancer patients in more effective weight management.

[Research Objectives] To compare the effectiveness of two intervention measures, the Diet, Exercise, and Mindfulness (DEM) model and the Diet and Exercise (DE) model, on weight loss, self-efficacy, mindfulness tendency, and quality of life.

[Research Method] The study will involve a quantitative study, which plans to carry out a randomized controlled trial (RCT). This trial will compare the effects of two intervention measures, the DEM model and the DE model, on weight loss, self-efficacy, mindfulness tendency, and quality of life.

[Expected Results] Through the intervention provided by this study, patients can engage in long-term online self-learning and supplementary learning after returning home, reducing the limitations of ineffective self-management learning caused by negative emotions, treatment side effects, and sequelae in the early stages of cancer. Healthcare professionals can also use scenario-based teaching materials produced by this study to guide breast cancer survivors with ineffective weight self-management skills in practicing the necessary skills. Additionally, through online learning, patients can learn and review without pressure, saving time on transportation, easing carbon foot print and relearning effective weight management skills; even if they have faced major life threats in the past, they can turn adversity into blessings, achieving a balance among physical, mental, and spiritual health.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 112
        • National Yang Ming Chiao Tung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • stage I-III breast cancer and completed treatment
  • Body mass index (BMI) is greater than or equal to 24 kg/m2
  • possess a smartphone

Exclusion Criteria:

  • Pregnant or planning to become pregnant within six months
  • Those who are unable to walk

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: DEM model
subjects participate diet, exercise and mindfulness programs
Participants will attend 8-week online dietary course. In addition to weekly classes, participants are required to photograph each meal.
Everyday walking steps more than 4000 steps. To accurately track participants' daily step counts, the research team provided quailfied pedometers.
Participants will attend 8-week online mindfulness course. In addition to weekly classes, participants practiced mindfulness individually for 5 minutes each day and maintained a mindfulness diary.
Active Comparator: DE model
subjects participate diet and exercise programs
Participants will attend 8-week online dietary course. In addition to weekly classes, participants are required to photograph each meal.
Everyday walking steps more than 4000 steps. To accurately track participants' daily step counts, the research team provided quailfied pedometers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological indicator I
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
BMI in kg/m2 (weight in kilograms divided by height in meters squared)
baseline, 8 weeks, 24 weeks, 48 weeks
Physiological indicator II
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
Waist circumference in centimeter
baseline, 8 weeks, 24 weeks, 48 weeks
Physiological indicator III
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
Body fat in percentage
baseline, 8 weeks, 24 weeks, 48 weeks
Physiological indicator IV
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
Muscle mass in kilograms
baseline, 8 weeks, 24 weeks, 48 weeks
Food Intake Frequency
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
Food Frequency Questionnaire
baseline, 8 weeks, 24 weeks, 48 weeks
Mindful Awareness Attention
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
The minimum value is 1 and maximum value is 6, and higher scores mean a better outcome.
baseline, 8 weeks, 24 weeks, 48 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Efficacy Lifestyle Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
The minimum value is 0 and maximum value is 10, and higher scores mean a better outcome.
baseline, 8 weeks, 24 weeks, 48 weeks
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
  1. Item 1 to 28 the minimum value is 1 and maximum value is 4, and lower scores mean a better outcome.
  2. Item 29 to 30 the minimum value is 1 and maximum value is 7, and higher scores mean a better outcome.
baseline, 8 weeks, 24 weeks, 48 weeks
Breast Cancer-Specific Quality of Life Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
The minimum value is 1 and maximum value is 4, and lower scores mean a better outcome.
baseline, 8 weeks, 24 weeks, 48 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Associate Professor, National Yang Ming Chiao Tung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 4, 2024

Primary Completion (Actual)

July 9, 2025

Study Completion (Actual)

July 9, 2025

Study Registration Dates

First Submitted

May 15, 2024

First Submitted That Met QC Criteria

May 22, 2024

First Posted (Actual)

May 24, 2024

Study Record Updates

Last Update Posted (Actual)

July 15, 2025

Last Update Submitted That Met QC Criteria

July 10, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Dietary program

Subscribe